Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00497432 · ClinicalTrials.gov registry record
Hyperbaric Oxygen Treatment in Patients With White Matter Hyperintensities
A clinical trial, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- Completed
- Registry status
- 20
- Enrollment target
NCT00497432 is a clinical trial that has completed, run by St. Luke's Hospital, Chesterfield, Missouri. The registered enrollment target is 20 participants.
The verdict
NCT00497432 has completed, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess whether hyperbaric oxygen treatment improves neurological function in patients who exhibit white matter hyperintensities on MRI examination. The secondary goal of this study is to determine if it is possible using MRI to discern a difference in perfusion of central nervous system tissue in regions of white matter hyperintensities after hyperbaric oxygen administration as compared to hyperbaric air.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-07 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00497432
The ClinicalTrials.gov registry entry for NCT00497432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's Hospital, Chesterfield, Missouri, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00497432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00497432 about?
NCT00497432 is a clinical study titled "Hyperbaric Oxygen Treatment in Patients With White Matter Hyperintensities". The primary purpose of this study is to assess whether hyperbaric oxygen treatment improves neurological function in patients who exhibit white matter hyperintensities on MRI examination. The secondary goal of this study is to determine if it is possible using MRI to discern a difference in perfusi...
What is the current status of trial NCT00497432?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2007-07. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT00497432?
This trial is sponsored by St. Luke's Hospital, Chesterfield, Missouri, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.